Astal Labs subsidiary appoints internal, cost and secretarial auditors for FY27
- Astal Laboratories' subsidiary Sriven Pharmachem appointed three auditors for FY27
- Mr. Balayogiswara Rao Peddinti named internal auditor; M/s Avnesh Jain & Co. as cost auditor
- M/s Mahendra Khandelwal & Co. appointed as secretarial auditor to enhance compliance

*this image is generated using AI for illustrative purposes only.
Astal Laboratories Limited disclosed that its material wholly owned subsidiary, Sriven Pharmachem India Private Limited (SPIPL), has appointed three key auditors for the financial year 2026-27. The appointments were approved by SPIPL's board of directors on September 28, 2026.
The move aims to comply with the Companies Act, 2013 and strengthen the secretarial and corporate compliance functions of the subsidiary. The disclosures were made under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Auditor Appointments Details
The board approved the following appointments effective for FY27:
| Role | Appointed Entity/Individual | Location/Profile |
|---|---|---|
| Internal Auditor | Mr. Balayogiswara Rao Peddinti | Finance professional with experience in plant finance and controls |
| Cost Auditor | M/s Avnesh Jain & Co. | Jaipur-based proprietorship firm headed by Mr. Avnesh Jain |
| Secretarial Auditor | M/s Mahendra Khandelwal & Co. | Proprietorship firm of Practicing Company Secretaries |
Professional Backgrounds
M/s Avnesh Jain & Co. is a cost accountancy firm with extensive experience in cost audit, budgeting, and project accounting. M/s Mahendra Khandelwal & Co., founded by CS Mahendra Prakash Khandelwal, provides services in corporate laws, SEBI regulations, and secretarial audits for listed entities. Mr. Balayogiswara Rao Peddinti brings expertise in accounts, finance, product costing, and statutory compliances.
The company stated that the relationships between directors were not applicable for these appointments as they are external auditor engagements rather than director appointments.
Historical Stock Returns for Astal Laboratories
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +1.91% | -3.54% | -11.75% | -0.03% | -30.98% | +543.54% |
How will the strengthened compliance framework at SPIPL impact Astal Laboratories' consolidated financial reporting accuracy for FY27?
What are the potential cost implications for Astal Laboratories given the appointment of three separate specialized audit firms?
Will the enhanced secretarial and internal audit controls at SPIPL influence future capital allocation decisions within the Astal group?


































